RBOTOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Vicarious Surgical Inc.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Apr 30, 2026

$0.02+0.00 (+11.11%)

Close on Oct 19, 2026

Market cap: $142.41K
P/E (TTM): –
Dividend yield: –

Vicarious Surgical Inc. cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Stock-Based Compensation	8.14	12	13	12	3.69	0.45
Other Non-Cash Items	0.49	-0.90	–	–	–	–
Change in Accounts Payable	-0.27	-0.10	-0.47	0.14	1.13	–
Operating Cash Flow	-45	-50	-62	-61	-33	-12
Capital Expenditures	-0.13	-0.18	-1.67	-5.35	-1.29	-0.12
Acquisitions	–	–	–	-1.20	–	–
Purchase of Investments	-21	-58	-76	–	–	–
Investing Cash Flow	32	6.86	-46	-5.35	-1.29	13
Stock Issued	–	–	47	10	–	–
Financing Cash Flow	5.76	0.01	45	9.15	192	14
Free Cash Flow	-45	-50	-64	-67	-35	-12
Interest Paid	0.00	–	0.00	0.04	0.04	0.00

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -177.5%

Financial strength

Current ratio: 1.54
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 42.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 0.04
Dividend yield: –